Free Trial
→ The one number Musk can't hide in the S-1 (From Behind the Markets) (Ad)tc pixel Free BIS Stock Alerts

ProShares UltraShort Nasdaq Biotechnology (BIS) Institutional Ownership

ProShares UltraShort Nasdaq Biotechnology logo
$8.29 +0.06 (+0.73%)
As of 12:09 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$162.47K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$98.41K
Get BIS Insider Trade Alerts

Want to know when executives and insiders are buying or selling ProShares UltraShort Nasdaq Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BIS Institutional Buying and Selling by Quarter

ProShares UltraShort Nasdaq Biotechnology Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Susquehanna International Group LLP23,932$313K0.0%-23.9%12.596%
10/28/2025 Csenge Advisory Group12,421$163K0.0%N/A6.537%
2/14/2025Jane Street Group LLC38,696$704K0.0%+267.8%19.348%
2/14/2025Tower Research Capital LLC TRC5,321$97K0.0%-65.5%2.661%
11/15/2024Jane Street Group LLC10,520$158K0.0%N/A4.782%
4/13/2024IMC Chicago LLC25,210$443K0.0%+68.1%11.459%
2/13/2024Tower Research Capital LLC TRC4,721$85K0.0%-53.4%1.004%
2/9/2024IMC Chicago LLC15,001$271K0.0%N/A3.192%
11/10/2022Tower Research Capital LLC TRC8,123$205K0.0%-9.2%2.708%
11/8/2022IMC Chicago LLC23,335$590K0.0%+11.1%7.778%
8/5/2022IMC Chicago LLC21,003$566K0.0%+12.5%5.251%
8/5/2022OLD Mission Capital LLC15,311$413K0.0%-52.5%3.828%
4/19/2022IMC Chicago LLC18,668$450K0.0%N/A5.395%
2/10/2022OLD Mission Capital LLC13,257$266K0.0%N/A3.348%


BIS Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of ProShares UltraShort Nasdaq Biotechnology shares: Jane Street Group LLC ($704K), Susquehanna International Group LLP ($313K), and Csenge Advisory Group ($163K), Tower Research Capital LLC TRC ($97K).Learn more on ProShares UltraShort Nasdaq Biotechnology's institutional investors.

The following institutional investors have purchased ProShares UltraShort Nasdaq Biotechnology's stock in the last 24 months: Jane Street Group LLC ($38.70K), and Csenge Advisory Group ($12.42K).

Institutional investors have bought a total of 12,421 shares in the last 24 months. This purchase volume represents approximately $162.47K in transactions.

The following institutional investors have sold ProShares UltraShort Nasdaq Biotechnology stock in the last 24 months: Susquehanna International Group LLP ($7.52K).

Institutional investors have sold a total of 7,524 shares in the last 24 months. This volume of shares sold represents approximately $98.41K in transactions.


Related Companies

This page (NASDAQ:BIS) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel
The one number Musk can't hide in the S-1
When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...
Behind the Markets | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Millionaire warns: Move your money before May 15
Larry Benedict - the trader who generated $274 million in client profits and beat the S&P 500 by 18 times in 2...
Brownstone Research | Sponsoredtc pixel